CRYO Cryo-Save

 

TIDMCRYO 
 
RNS Number : 5781L 
Cryo-Save Group NV 
10 May 2010 
 

10 May 2010 
 
Cryo-Save Group N.V. 
 
Storage volumes up 5% with strong growth in combined cord storage 
 
Cryo-Save Group N.V. (AIM/Euronext: CRYO, or 'the Group'), Europe's leading stem 
cell bank, announces its  trading update for the three months to 31 March 2010. 
 
Highlights for the period were: 
 
·      The number of new customers who stored stem cells from the umbilical cord 
blood and cord tissue in Q1 2010 was 6,600, up 5% (Q1 2009: 6,300). The total 
number of samples stored was approximately 128,800 at 31 March 2010 
·      Over 30% of these new customers opted for the new combined service of 
storing stem cells from the umbilical cord blood (haematopoietic stem cells) as 
well as the cord tissue (containing mesenchymal stem cells) 
·      Cryo-Save increased its shareholding of Sejtbank, Hungary and Cryo-Save 
Czech Republic from 70% to 100%, for a total consideration of EUR1.4 million 
 
·      Cryo-Save began participation in project Hyperlab, a stem cell research 
project which is subsidized by the European Commission, in cooperation with 
several well known research institutes (www.hyperlab.eu/partners.php) 
 
·      Cryo-Lip :In the first quarter of 2010 Cryo-Save signed contracts with 
some of the top plastic surgery clinics in Europe for the introduction of the 
new Cryo-Lip  service. Cryo-Lip enables adults, who have already chosen to have 
liposuction, to store the stem cells collected from the fat. Cryo-Lip  will be 
introduced in a number of countries in the second quarter of 2010 
 
 
Highlights after 31 March 2010 were: 
 
·      Cryo-Save acted quickly to minimize the transport disruption caused by 
the volcanic ash cloud by temporarily using road transport throughout Europe. 
Almost all samples were received in time, in compliance with Cryo-Save's 
standards, at its facilities for processing and storage. To handle all samples 
with the greatest care, the facilities were open 24 hours 7 days a week 
 
 
·      As previously announced Arnoud van Tulder took over as Chief Executive on 
1 May 2010. Prior to this he was Group CFO. He succeeded co-founder Marc 
Waeterschoot who will remain an Executive Director and member of the Board. As 
of 1 June, Mr Perry Buuron is appointed as finance director (non-statutory) 
 
 
Enquiries: 
 
+-------------------------------------+---------------------+ 
| Cryo-Save Group                     | +  31 (0)575 548998 | 
+-------------------------------------+---------------------+ 
| Arnoud van Tulder, Chief Executive  |                     | 
| Officer                             |                     | 
+-------------------------------------+---------------------+ 
| Marc Waeterschoot, Executive        |                     | 
| Director                            |                     | 
+-------------------------------------+---------------------+ 
| Daniel Stewart & Company plc        |     + 44 (0)20 7776 | 
|                                     |                6550 | 
+-------------------------------------+---------------------+ 
| Simon Leathers/Emma Earl            |                     | 
+-------------------------------------+---------------------+ 
|                                     |                     | 
+-------------------------------------+---------------------+ 
| College Hill (UK)                   |     + 44 (0)20 7457 | 
|                                     |                2020 | 
+-------------------------------------+---------------------+ 
| Adrian Duffield/Rozi Morris         |                     | 
+-------------------------------------+---------------------+ 
|                                     |                     | 
+-------------------------------------+---------------------+ 
| SPJ Financiële Communicatie         |  +31 (0)20 647 8181 | 
| Amstelveen (NL)                     |                     | 
+-------------------------------------+---------------------+ 
| Kees Jongsma/Léon Melens            |                     | 
+-------------------------------------+---------------------+ 
 
 
About Cryo-Save 
 
With more than 130,000 samples saved, Cryo-Save is the leading stem cell bank in 
Europe and one of the fastest growing in the world. Driven by its international 
business strategy, Cryo-Save is now represented in 38 countries on three 
continents and has state-of-the-art processing facilities in Belgium, Germany, 
Dubai, India and France (under construction). 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCEDLFBBEFEBBD 
 

Cryo-Save (LSE:CRYO)
Historical Stock Chart
From Dec 2024 to Jan 2025

Cryo-Save (LSE:CRYO)
Historical Stock Chart
From Jan 2024 to Jan 2025